Skip to main content
. 2020 May 7;106(6):1684–1692. doi: 10.3324/haematol.2019.243287

Figure 3.

Figure 3.

Progression-free survival according to CD20 content. (A) Kaplan-Meier plots of progression-free survival (PFS) in the study cohort for the two risk groups according to B-cell content (CD20-positive cell rate: ≤21% or >21%). (B) Kaplan-Meier plots of PFS in the validation cohort for the two risk groups according to Bcell content (CD20-positive cell rate: ≤10% or >10%).